FLong-QT therapy（Sharp Therapeutics）

N/A

Report date: 2022/12/16 17:04:25
NME

Base Information

Drug NameFLong-QT therapy（Sharp Therapeutics）
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv11.1 blockers
TargetsVoltage-gated potassium channel subunit Kv11.1
Therapy Area/IndicationsLong QT Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSharp Therapeutics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSharp Therapeutics Pvt Ltd
Inactive CompaniesN/A
Active IndicationsLong QT Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A